Achillion Pharma (ACHN) Announces Presentation of ODV + AL-335 Phase 2a Data
Go back to Achillion Pharma (ACHN) Announces Presentation of ODV + AL-335 Phase 2a Data| Achillion Pharmaceuticals, Inc. (AMEX: ACHN) | Delayed: 0.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.79 | 52 Week High | $10.95 | |||
| Open | $0.79 | 52 Week Low | $3.78 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.79 | EPS | $-0.63 | |||
| Volume | 239,195 | |||||
| Johnson & Johnson (NYSE: JNJ) | Delayed: 146.82 -1.71 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.53 | 52 Week High | $126.07 | |||
| Open | $149.37 | 52 Week Low | $94.28 | |||
| Day High | $149.58 | P/E | 30.52 | |||
| Day Low | $146.33 | EPS | $4.81 | |||
| Volume | 7,641,941 | |||||
